Literature DB >> 22539319

Separation principles of cycling temperature capillary electrophoresis.

Per Olaf Ekstrøm1, David J Warren, William G Thilly.   

Abstract

High throughput means to detect and quantify low-frequency mutations (<10(-2) ) in the DNA-coding sequences of human tissues and pathological lesions are required to discover the kinds, numbers, and rates of genetic mutations that (i) confer inherited risk for disease or (ii) arise in somatic tissues as events required for clonal diseases such as cancers and atherosclerotic plaque.While throughput of linear DNA sequencing methods has increased dramatically, such methods are limited by high error rates (>10(-3) ) rendering them unsuitable for the detection of low-frequency risk-conferring mutations among the many neutral mutations carried in the general population or formed in tissue growth and development. In contrast, constant denaturing capillary electrophoresis (CDCE), coupled with high-fidelity PCR, achieved a point mutation detection limit of <10(-5) in exon-sized sequences from human tissue or pooled blood samples. However, increasing CDCE throughput proved difficult due to the need for precise temperature control and the time-consuming optimization steps for each DNA sequence probed. Both of these problems have been solved by the method of cycling temperature capillary electrophoresis (CTCE). The data presented here provide a deeper understanding of the separation principles involved in CTCE and address several elements of a previously presented two-state transport model.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539319     DOI: 10.1002/elps.201100550

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  5 in total

1.  Ten modifiers of BRCA1 penetrance validated in a Norwegian series.

Authors:  Cecilie Heramb; Per Olaf Ekstrøm; Kukatharmini Tharmaratnam; Eivind Hovig; Pål Møller; Lovise Mæhle
Journal:  Hered Cancer Clin Pract       Date:  2015-05-30       Impact factor: 2.857

2.  TP53/p53 alterations and Aurora A expression in progressor and non-progressor colectomies from patients with longstanding ulcerative colitis.

Authors:  Mariann Friis-Ottessen; Espen Burum-Auensen; Aasa R Schjølberg; Per Olaf Ekstrøm; Solveig N Andersen; Ole Petter Clausen; Paula M De Angelis
Journal:  Int J Mol Med       Date:  2014-10-20       Impact factor: 4.101

3.  Mapping mitochondrial heteroplasmy in a Leydig tumor by laser capture micro-dissection and cycling temperature capillary electrophoresis.

Authors:  Paulo Refinetti; Christian Arstad; William G Thilly; Stephan Morgenthaler; Per Olaf Ekstrøm
Journal:  BMC Clin Pathol       Date:  2017-04-08

4.  Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing.

Authors:  Mev Dominguez-Valentin; Sigve Nakken; Hélène Tubeuf; Daniel Vodak; Per Olaf Ekstrøm; Anke M Nissen; Monika Morak; Elke Holinski-Feder; Arild Holth; Gabriel Capella; Ben Davidson; D Gareth Evans; Alexandra Martins; Pål Møller; Eivind Hovig
Journal:  Sci Rep       Date:  2019-12-06       Impact factor: 4.379

5.  Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds.

Authors:  Mev Dominguez-Valentin; D Gareth R Evans; Sigve Nakken; Hélène Tubeuf; Daniel Vodak; Per Olaf Ekstrøm; Anke M Nissen; Monika Morak; Elke Holinski-Feder; Alexandra Martins; Pål Møller; Eivind Hovig
Journal:  Hered Cancer Clin Pract       Date:  2018-01-15       Impact factor: 2.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.